PERSPECTA

News from every angle

Back to headlines

Novo Nordisk and Eli Lilly Fined for Drug Advertisements

The French drug safety agency ANSM has fined pharmaceutical companies Novo Nordisk and Eli Lilly for advertisements related to weight management drugs in France.

PostShare

Sources

Showing 0 of 1 sources

No articles available in your preferred languages.

1 article available in other languages below.